Pharmazz, Dr Reddy’s enter licensing pact to market Centhaquine in India EP News Bureau Mar 22, 2024 Centhaquine is a resuscitative agent to treat hypovolemic shock by increasing stroke volume and cardiac output due to an increase…
Centhaquine set to enter US-FDA approved Phase 3 clinical trial in US and Europe EP News Bureau Aug 2, 2023 Pharmazz India obtained marketing authorization for the management of Hypovolemic shock Lyfaquin (INN: Centhaquine) in India in…
